Company Information
CIN
Status
Date of Incorporation
18 May 2012
State / ROC
Gwalior / ROC Gwalior
Last Balance Sheet
31 March 2023
Last Annual Meeting
30 September 2023
Paid Up Capital
400,000
Authorised Capital
1,000,000
Directors
Shailendra Kumar Gupta
Director
over 12 years ago
over 12 years ago
Radheshyam Gupta
Director
over 13 years ago
over 13 years ago
Registered Trademarks
[Class : 5] Medicinal, Ayurvedic & Pharmaceutical Preparations
[Class : 5] Medicinal, Ayurvedic & Pharmaceutical Preparations
[Class : 5] Medicinal, Ayurvedic & Pharmaceutical Preparations
View +3 more Brands for Kinjal Biotech Private Limited.
Documents
Form MGT-7-24112019_signed
Form AOC-4-24112019_signed
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-14112019
Directors report as per section 134(3)-14112019
List of share holders, debenture holders;-14112019
Form DPT-3-04112019-signed
Form DPT-3-05082019-signed
Auditor?s certificate-30062019
Auditor?s certificate-27062019
Form MGT-7-29122018_signed
Form AOC-4-29122018_signed
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-28122018
List of share holders, debenture holders;-28122018
Directors report as per section 134(3)-28122018
Form ADT-1-30102017_signed
Copy of resolution passed by the company-30102017
List of share holders, debenture holders;-30102017
Copy of written consent given by auditor-30102017
Copy of the intimation sent by company-30102017
Form MGT-7-30102017_signed
Form AOC-4-29102017_signed
Directors report as per section 134(3)-27102017
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-27102017
Form ADT-1-29102016_signed
Copy of the intimation sent by company-28102016
Copy of written consent given by auditor-28102016
Copy of resolution passed by the company-28102016
Form MGT-7-24102016_signed
Optional Attachment-(1)-21102016
Optional Attachment-(2)-21102016
